glp-1 gastrointestinal obstruction law office in louisiana lawmakers are considering a bill that would expand Medicaid access to drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Louisiana Patients Are Losing Coverage

The study published in JAMA Psychiatry found that patients with alcohol use disorder (AUD) who were prescribed GLP-1 drugs, popularly known by their brand names Ozempic and Wegovy, had a significantly lower risk of hospitalization for alcohol-related issues.Background on Semaglutide and LiraglutideSemaglutide and liraglutide are medications b

For years, GLP-1 medications meant one thing to most people: expensive injections for weight loss that insurance would not cover

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

Pfizer's obesity pill danuglipron has not progressed to Phase 3 trials and is not approved in the UK

Multi-strain probiotic complex complementary probiotic strains selected to work synergistically with Akkermansia, supporting the complete gut microbiome environment for digestive regularity, gut barrier function and microbial diversity

The return is eligible for first-time buyers only